Researchers bank samples to unlock secrets of brain tumors

NCT ID NCT02851706

Completed Knowledge-focused Sponsor: National Cancer Institute (NCI) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This completed study enrolled over 1,200 people with brain or spinal cord tumors to collect medical information, blood samples, and tumor tissue. The goal was to better understand these cancers and identify promising areas for future research. Participants also received guidance on managing their illness and potential new treatment options.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help researchers identify new areas for brain and spinal cord tumor research and improve future treatment options.
What could go wrong: This is an observational study, not a treatment trial. It does not test any new therapy, so there is no direct benefit to participants. Results may take years to influence patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

astrocytoma (excluding glioblastoma) brain cancer brain neoplasm central nervous system cancer glioma neoplasm spinal cord cancer spinal cord neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN CANCER BRAIN TUMOR NEOPLASM SPINE CANCER SPINE TUMOR

Contacts and locations

Locations

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.